Sheffield-headquartered aquaculture biotechnology company, Benchmark, has completed the sale of its genetics business area to ...

Novo Nordisk has experienced a 50% drop due to potential tariffs and recent clinical trial results. Read why I rate NVO stock a strong buy right now.

Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain ...

Shareholders with any queries in relation to their Novo holding are advised to contact Automic at [email protected] or on 1300 288 664 (within Australia) or +61 2 9698 5414 (outside Australia) ...

Merck signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion.

Supira Medical, Inc., today announced the successful completion of an oversubscribed Series E financing round, raising $120M ...

Supira Medical has completed a $120m Series E funding round, with plans to use the capital to advance its position in the ...

Supira Medical, Inc. (Supira), a clinical-stage Shifamed portfolio company, today announced the successful completion of an oversubscribed Series E financing round, raising $120M to accelerate the ...

Led by alums from Takeda and Boston Pharmaceuticals, Hillstar Bio is working on treatments that remove harmful immune cells to relieve disease.

Shares plummet after announcement, as Wojcicki says she aims to secure the assets of the popular DNA-testing company. Dun & Bradstreet Holdings agreed to be acquired by private equity firm Clearlake ...